MIRA INFORM REPORT

 

 

Report No. :

319926

Report Date :

30.04.2015

 

IDENTIFICATION DETAILS

 

Name :

WATSON PHARMA PRIVATE LIMITED

 

 

Registered Office :

21-22, Kalpataru Square, Kondivita Off Andheri Kurla Road, Andheri (East), Mumbai – 400059, Maharashtra

Tel. No.:

91-22-66886700

 

 

Country :

India

 

 

Financials (as on) :

31.12.2013

 

 

Date of Incorporation :

21.10.2005

 

 

Com. Reg. No.:

11-156968

 

 

Capital Investment / Paid-up Capital :

Rs.550.025 Millions

 

 

CIN No.:

[Company Identification No.]

U24230MH2005PTC156968

 

 

IEC No.:

Not Available

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMW02844C

 

 

PAN No.:

[Permanent Account No.]

AAACW6074D

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturing of pharmaceuticals.

 

 

No. of Employees :

Information denied by the management

 

 

RATING & COMMENTS

 

MIRA’s Rating :

A (57)

 

RATING

STATUS

PROPOSED CREDIT LINE

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

 

Status :

Good

 

 

 

 

Payment Behaviour :

Regular

 

 

 

 

Litigation :

Clear

 

 

 

 

Comments :

Subject is an established company having fine track record.

 

Fundamentals of the company is decent. Financial position of the company is strong and healthy. There are no external borrowing recorded by the company.

 

Trade relation reported to be fair. Business is active. Payment terms are reported to be regular and as per commitment.

 

The company can be considered normal for business dealing at usual trade terms and conditions.

 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

 

INFORMATION PARTED BY

 

Name :

Mr. Shyam Dhongre

Designation :

Account Manager

Contact No.:

91-22-66886700

Date :

28.04.2014

 

 

LOCATIONS

 

Registered Office :

21-22, Kalpataru Square, Kondivita Off Andheri Kurla Road, Andheri (East), Mumbai – 400059, Maharashtra, India 

Tel. No.:

91-22-66886700

Fax No.:

91-22-66886799

E-Mail :

rajesh.sharma@watsonpharm.co.in

sekhchem@bom3.vsnl.net.in

muralidharan.cs@watsonpharma.co.in

shivshanker.shenoy@watsonpharm.co.in

vishal.kulkarni@watsonpharm.co.in

manoj.ehalve@watsopharm.co.in

Website :

www.watson.com

 

 

Factory :

Plot No. A3 to A6, Phase I-A, Verna Industrial Estate, Unit IV, Verna Salcettle - 403722, Goa, India

 

 

DIRECTORS

 

As on 29.05.2014

 

Name :

Mr. David Adam Irving Buchen

Designation :

Director

Address :

1967, LA France Avenue, South Pasadena, California – 91030, United States of America

Date of Birth/Age :

22.06.1964

Date of Appointment :

21.10.2005

DIN No.:

00839184

 

 

Name :

Patrick Gerard Brunner

Designation :

Director

Address :

10231, Key Plum ST, Plantation, Florida – 333248265, United States of America

Date of Birth/Age :

13.06.1963

Date of Appointment :

20.05.2010

DIN No.:

03024470

 

 

Name :

Mr. Muralidharan Sundaresan Chinnadharavaram

Designation :

Managing Director

Address :

302 B Wing, Avalon Building, Hirenandani Garden, Powai, Mumbai – 400 076, Maharashtra, India

Date of Birth/Age :

05.02.1963

Date of Appointment :

20.05.2010

DIN No.:

00014740

 

 

Name :

Mr. Krishnaprasad Chandrasekara Hassan

Designation :

Director

Address :

A 502, Dream Heights, Plot No. 28, Kharghar, Sector – 19, Navi Mumbai – 410210, Maharashtra, India

Date of Birth/Age :

29.08.1966

Date of Appointment :

30.09.2013

DIN No.:

06719389

 

 

Name :

Mr. Jayant Shyam Sunder Bapna

Designation :

Director

Address :

6 Cutler CT, Suffern, New York 10901, United States of America

Date of Birth/Age :

17.07.1958

Date of Appointment :

23.05.2011

DIN No.:

03511093

 

 

Name :

Mr. Robert Allan Stewart

Designation :

Director

Address :

Heritage Village VIII, 4 Quail Run BLK 47.02 LT 1.02 Randolph New Jersey - 07869, United States of America

Date of Birth/Age :

03.05.1967

Date of Appointment :

23.05.2011

DIN No.:

03515778

 

 

Name :

Mr. Philip Abraham Biju

Designation :

Director

Address :

Supreme Mill Tower, Flat 204, Alto Monte, Margao – 403 601, Goa, India

Date of Birth/Age :

04.11.1969

Date of Appointment :

23.05.2011

DIN No.:

03515838

 

 

KEY EXECUTIVES

 

Name :

Mr. Shyam Dhongre

Designation :

Account Manager

 

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 29.05.2014

 

Names of Shareholders

 

No. of Shares

Watson Laboratories Inc, USA

 

55002460

Watson Pharma Inc, Parsippany

 

1

Total

 

55002461

 

 

Equity Share Break up (Percentage of Total Equity)

 

As on 29.05.2014

 

Category

Percentage

Foreign holdings( Foreign institutional investor(s), Foreign companie(s) Foreign financial institution(s), Non-resident Indian(s) or Overseas Corporate bodies or Others

100.00

Total

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturing of pharmaceuticals.

 

 

Products :

Item Code No.

Product Description

2942 00 90

Imiquimod Bulk Drug

3004 90 69

Carisoprodol Tablets

3004 90 39

Minocycline Capsules

3004 39 12

Other – Prednisone Tablets

3004 90 71

Other – Lisinopril Tablets

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Available

 

 

Imports :

Not Available

 

 

Terms :

 

Selling :

Not Available

 

 

Purchasing :

Not Available

 

PRODUCTION STATUS (As on : 31.12.2011)

 

Particulars

Unit

Installed Capacity

Actual Production

Drugs and Pharmaceuticals

 

 

 

Active Pharmaceutical Ingredients

Tones

112

86

Formulations – Tablets and Capsules

Million Nos.

3000

2855

 

*Licensed Capacity is not applicable as industrial licensing has been abolished in respect of these products vide Notification No. SO-477(E) dated 25th July, 1991 as amended vide Press Release Note No. 4 of the 1994 series dated 25th October, 1994 issued by the Department of Industrial Development, Ministry of Industry, Government of India

 

'@Installed Capacity (Active Pharmaceutical Ingredients at Ambernath plant on triple shift basis, Formulations at Goa plant on triple shift basis and Formulations at Ambernath plant on single shift basis) being a technical matter, is certified by the management and relied upon by the auditors.

 

 

GENERAL INFORMATION

 

Suppliers :

Reference :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Experience :

Not Divulged

Maximum Limit Dealt :

Not Divulged

 

 

Customers :

Reference :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Experience :

Not Divulged

Maximum Limit Dealt :

Not Divulged

 

 

No. of Employees :

Information declined by the management.

 

 

Bankers :

  • HDFC Bank Limited, HDFC Bank Housesenapati Bapat Marg, Lower Parel W, Mumbai - 400013, Maharashtra, India
  • Standard Chartered Bank, Mumbai Branch, 90 Mg Road, Mumbai - 400001, Maharashtra, India

 

 

 

 

 

Auditors :

 

Name :

Lovelock and Lewes

Chartered Accountants

Address :

252, Veer Savarkar Marg, Shivaji Park, Dadar, Mumbai – 400 028, Maharashtra, India

PAN No.:

AABFL5878L

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Ultimate Holding Company :

  • Actavis, Inc., USA (formerly Watson Pharmaceuticals, Inc.) (up to 30th September, 2013)
  • Actavis plc., Ireland (from 1st October, 2013)

 

 

Holding Company :

  • Watson Laboratories, Inc., USA

 

 

Fellow Subsidiaries :

  • Actavis, Inc., USA (from 1st October, 2013)
  • Actavis Farmaceutica Ltda, Brazil (formerly Arrow Farmaceutica Ltda)
  • Arrow No. 7 Limited, UK
  • Arrow Pharma (Malta) Limited, Malta
  • Cobalt Pharmaceuticals Inc., Canada
  • Specifar Pharmaceuticals, Greece
  • Watson Pharma (PTY) Limited., South Africa
  • Spirit Pharmaceuticals Pty Limited., Australia
  • Actavis Mid-Atlantic LLC, USA
  • Actavis Group PTC Ehf, Iceland
  • Actavis Pharma Manufacturing Private Limited, India (up to 31st July, 2013)
  • Lotus Labs Private Limited, India
  • Watson Pharma Inc., USA
  • Actavis KK, Japan
  • Actavis PTY Limited, Australia

 

 

CAPITAL STRUCTURE

 

As on 31.12.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

75000000

Equity Shares

Rs.10/- each

Rs.750.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

55002461

Equity Shares

Rs.10/- each

Rs.550.025 Millions

 

 

 

 

 

 

FINANCIAL DATA

[all figures are in Rupees Million]

 

 

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.12.2013

31.12.2012

31.12.2011

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

550.025

550.025

550.025

(b) Reserves & Surplus

5171.215

4614.921

3939.668

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

5721.240

5164.946

4489.693

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

0.000

0.000

545.193

(b) Deferred tax liabilities (Net)

243.247

258.658

196.111

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

61.815

25.677

14.029

Total Non-current Liabilities (3)

305.062

284.335

755.333

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

0.000

0.000

0.000

(b) Trade payables

852.634

732.988

735.698

(c) Other current liabilities

260.276

766.065

794.008

(d) Short-term provisions

18.374

32.448

9.686

Total Current Liabilities (4)

1131.284

1531.501

1539.392

 

 

 

 

TOTAL

7157.586

6980.782

6784.418

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

3234.258

3268.962

2764.305

(ii) Intangible Assets

66.312

66.440

46.988

(iii) Capital work-in-progress

642.426

223.350

482.876

(iv) Intangible assets under development

0.083

19.309

3.879

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

589.373

478.578

510.212

(e) Other Non-current assets

1.618

1.439

1.333

Total Non-Current Assets

4534.070

4058.078

3809.593

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

226.795

50.238

(b) Inventories

2121.343

2084.216

1766.609

(c) Trade receivables

322.364

394.044

296.462

(d) Cash and cash equivalents

113.834

107.836

590.382

(e) Short-term loans and advances

65.537

109.263

267.000

(f) Other current assets

0.438

0.550

4.134

Total Current Assets

2623.516

2922.704

2974.825

 

 

 

 

TOTAL

7157.586

6980.782

6784.418

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.12.2013

31.12.2012

31.12.2011

 

SALES

 

 

 

 

 

Income

7295.821

6990.709

5453.653

 

 

Other Income

NA

NA

NA

 

 

TOTAL                                         (A)

NA

NA

NA

 

 

 

 

 

 

EXPENSES

NA

NA

NA

 

 

 

 

 

Less

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

1273.196

1376.525

966.813

 

 

 

 

 

Less

FINANCIAL EXPENSES

3.343

11.996

11.924

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION 

1269.853

1364.529

954.889

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION

409.922

360.755

322.128

 

 

 

 

 

 

PROFIT BEFORE TAXATION AND PRIOR PERIOD ITEMS

859.931

1003.774

632.761

 

 

 

 

 

 Less

PRIOR PERIOD ITEMS

0.000

7.316

30.616

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

859.931

996.458

602.145

 

 

 

 

 

Less

TAX

303.637

321.205

158.671

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX 

556.294

675.253

443.474

 

 

 

 

 

 

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD 

2806.930

2131.677

1688.202

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

3363.224

2806.930

2131.677

 

 

 

 

 

 

Earnings Per Share (Rs.)

 10.11

12.28

8.06

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.12.2013

31.12.2012

31.12.2011

 

 

 

 

 

Net Profit Margin

PAT / Sales

(%)

7.62

9.66

8.13

 

 

 

 

 

Operating Profit Margin

(PBDIT/Sales)

(%)

17.45

19.69

17.73

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

13.20

14.79

9.56

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.15

0.19

0.13

 

 

 

 

 

Debt Equity Ratio

(Total Debts/Networth)

 

0.00

0.00

0.12

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

2.32

1.91

1.93

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

DEBT EQUITY RATIO

 

Particular

31.12.2011

31.12.2012

31.12.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Share Capital

550.025

550.025

550.025

Reserves & Surplus

3939.668

4614.921

5171.215

Net worth

4489.693

5164.946

5721.240

 

 

 

 

long-term borrowings

545.193

0.000

0.000

Short term borrowings

0.000

0.000

0.000

Total borrowings

545.193

0.000

0.000

Debt/Equity ratio

0.121

0.000

0.000

 

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.12.2011

31.12.2012

31.12.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

5453.653

6990.709

7295.821

 

 

28.184

4.365

 

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.12.2011

31.12.2012

31.12.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

5453.653

6990.709

7295.821

Profit

443.474

675.253

556.294

 

8.13%

9.66%

7.62%

 

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

CURRENT MATURITIES OF LONG TERM DEBTS

 

Particulars

31.03.2013

(Rs. In Millions)

31.03.2012

(Rs. In Millions)

31.03.2011

(Rs. In Millions)

Current Maturities of Long Term Debts

0.000

549.890

545.193

 

 

 

 

Total

0.000

549.890

545.193

 

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

INDEX OF CHARGE:

 

Sr. No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

10163588

23/06/2009

250,000,000.00

HDFC BANK LIMITED

HDFC Bank House Senapati Bapat Marg, Lower Parel W, Mumbai, Maharashtra - 400013, India

A64359128

 

*Date of modification Charges

 

 

FIXED ASSETS:

 

œ  Land

œ  Building

œ  Plant and Machinery

œ  Computer

œ  Vehicles

œ  Furniture and Fixture

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 63.33

UK Pound

1

Rs. 96.52

Euro

1

Rs. 68.93

 

 

INFORMATION DETAILS

 

Information Gathered by :

PPT

 

 

Analysis Done by :

DIV

 

 

Report Prepared by :

JYO


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

6

OPERATING SCALE

1~10

7

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

7

--PROFITABILITY

1~10

6

--LIQUIDITY

1~10

7

--LEVERAGE

1~10

6

--RESERVES

1~10

6

--CREDIT LINES

1~10

6

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

57

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.